Resource

 

 

 

 

 

 

 

 

 

 

 

Finance & Banking

Baker & McKenzie Affiliate Advises the Financial Advisors and Lead Managers On USD6 billion NCB IPO

24 Oct 2014

Legal Advisors, Abdulaziz I. Al-Ajlan & Partners In Association with Baker & McKenzie has advised the financial advisors and lead managers on the initial public offering (IPO) of The National Commercial Bank, Saudi Arabia's largest lender.

The deal, raising SAR22.5 billion (USD6 billion), is the second-largest IPO in the world this year and the largest-ever equity sale in the Middle East, surpassing the USD5 billion raised by Dubai’s DP World in 2007.

Hengeler Mueller advises Oddo & Cie on acquisition of Close Brothers Seydler Bank

24 Oct 2014

Oddo & Cie, Paris, a leading independent broker on French midcaps, is acquiring Close Brothers Seydler Bank AG, Frankfurt am Main, from the London-based Close Brothers Group Plc. The future company will take the name of Oddo Seydler. The transaction is subject to approval by the relevant regulatory authorities.

Shearman & Sterling Advises Arrangers in $725 Million Acquisition Financing of Grocery Outlet by Hellman & Friedman

24 Oct 2014

Shearman & Sterling advised Morgan Stanley Senior Funding, Inc., Deutsche Bank Securities Inc. and Jefferies Finance LLC as joint lead arrangers and joint bookrunners in connection with a $725 million financing, comprising of a $450 million first lien term loan facility, a $75 million revolving credit facility and a $200 million second lien term loan facility, related to the acquisition of Grocery Outlet Inc. by Hellman & Friedman LLC.

Shearman & Sterling Advises Underwriters in Atmos Energy’s $500 Million Offering of Senior Notes

24 Oct 2014

Shearman & Sterling acted as counsel to the underwriters, represented by Credit Agricole Securities (USA) Inc., Merrill Lynch, Pierce, Fenner & Smith Incorporated and Wells Fargo Securities, LLC, in connection with Atmos Energy’s offering of $500 million aggregate principal amount of 4.125% Senior Notes due 2044.

Esperion Therapeutics, Inc. Common Stock Offering

24 Oct 2014

Davis Polk advised J.P. Morgan and BofA Merrill Lynch as representatives of the several underwriters on a $97.8 million SEC-registered offering of common stock of Esperion Therapeutics, Inc., which includes the full exercise of the underwriters’ option to purchase additional shares. The common stock is listed on the NASDAQ Global Market under the symbol “ESPR.”